APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preclinical Pharmacokinetics Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Preclinical Pharmacokinetics Services Market Outlook and Growth Opportunities 2026

6 March 2026202 pages

Choose your research edition.

Industry ResearchPreclinical Pharmacokinetics Services Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Preclinical Pharmacokinetics Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Preclinical Pharmacokinetics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preclinical Pharmacokinetics Services Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Preclinical Pharmacokinetics Services Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Preclinical Pharmacokinetics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Preclinical Pharmacokinetics Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Preclinical Pharmacokinetics Services market include Porsolt, Altasciences, Biocytogen, Charles River Laboratories, WuXi AppTec, PyschoGenics, Evotec (Cyprotex), QPS and Aurigene Pharmaceutical Services, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Preclinical Pharmacokinetics Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Preclinical Pharmacokinetics Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Preclinical Pharmacokinetics Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Preclinical Pharmacokinetics Services market.

Preclinical Pharmacokinetics Services Segment by Company

Porsolt

Altasciences

Biocytogen

Charles River Laboratories

WuXi AppTec

PyschoGenics

Evotec (Cyprotex)

QPS

Aurigene Pharmaceutical Services

Frontage Laboratories

Dalriada

Sygnature Discovery

Admescope

Imavita

IQVIA Laboratories

Pharmaron

Preclinical Pharmacokinetics Services Segment by Type

LC-MS/MS-Based Preclinical Pharmacokinetics Service

Immunoassay-Based Preclinical Pharmacokinetics Service

Others

Preclinical Pharmacokinetics Services Segment by Application

Innovative Small Molecule Drugs

Biopharmaceuticals

Traditional Chinese Medicine & Natural Products

Others

Preclinical Pharmacokinetics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Preclinical Pharmacokinetics Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Preclinical Pharmacokinetics Services key companies, revenue, market share, and recent developments.

3. To split the Preclinical Pharmacokinetics Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Preclinical Pharmacokinetics Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Preclinical Pharmacokinetics Services significant trends, drivers, influence factors in global and regions.

6. To analyze Preclinical Pharmacokinetics Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preclinical Pharmacokinetics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preclinical Pharmacokinetics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preclinical Pharmacokinetics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Preclinical Pharmacokinetics Services industry.

Chapter 3: Detailed analysis of Preclinical Pharmacokinetics Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Preclinical Pharmacokinetics Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Preclinical Pharmacokinetics Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Preclinical Pharmacokinetics Services Industry Trends Table 2. Preclinical Pharmacokinetics Services Industry Drivers Table 3. Preclinical Pharmacokinetics Services Industry Opportunities and Challenges Table 4. Preclinical Pharmacokinetics Services Industry Restraints Table 5. Global Preclinical Pharmacokinetics Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Preclinical Pharmacokinetics Services Revenue Share by Company (2021-2026) Table 7. Global Preclinical Pharmacokinetics Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Preclinical Pharmacokinetics Services Key Company Manufacturing Base & Headquarters Table 9. Global Preclinical Pharmacokinetics Services Company, Product Type & Application Table 10. Global Preclinical Pharmacokinetics Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Preclinical Pharmacokinetics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of LC-MS/MS-Based Preclinical Pharmacokinetics Service Table 15. Significant Companies of Immunoassay-Based Preclinical Pharmacokinetics Service Table 16. Significant Companies of Others Table 17. Global Preclinical Pharmacokinetics Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Preclinical Pharmacokinetics Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Preclinical Pharmacokinetics Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Preclinical Pharmacokinetics Services Sales Value Share by Type (2021-2026) Table 21. Global Preclinical Pharmacokinetics Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Innovative Small Molecule Drugs Table 23. Significant Companies of Biopharmaceuticals Table 24. Significant Companies of Traditional Chinese Medicine & Natural Products Table 25. Significant Companies of Others Table 26. Global Preclinical Pharmacokinetics Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Preclinical Pharmacokinetics Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Preclinical Pharmacokinetics Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Preclinical Pharmacokinetics Services Sales Value Share by Application (2021-2026) Table 30. Global Preclinical Pharmacokinetics Services Sales Value Share by Application (2027-2032) Table 31. Global Preclinical Pharmacokinetics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Preclinical Pharmacokinetics Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Preclinical Pharmacokinetics Services Sales Value Share by Region (2021-2026) Table 34. Global Preclinical Pharmacokinetics Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Preclinical Pharmacokinetics Services Sales Value Share by Region (2027-2032) Table 36. Global Preclinical Pharmacokinetics Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Preclinical Pharmacokinetics Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Preclinical Pharmacokinetics Services Sales Value Market Share by Country (2021-2026) Table 39. Global Preclinical Pharmacokinetics Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Preclinical Pharmacokinetics Services Sales Value Market Share by Country (2027-2032) Table 41. Porsolt Company Information Table 42. Porsolt Business Overview Table 43. Porsolt Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Porsolt Preclinical Pharmacokinetics Services Product Portfolio Table 45. Porsolt Recent Development Table 46. Altasciences Company Information Table 47. Altasciences Business Overview Table 48. Altasciences Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Altasciences Preclinical Pharmacokinetics Services Product Portfolio Table 50. Altasciences Recent Development Table 51. Biocytogen Company Information Table 52. Biocytogen Business Overview Table 53. Biocytogen Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Biocytogen Preclinical Pharmacokinetics Services Product Portfolio Table 55. Biocytogen Recent Development Table 56. Charles River Laboratories Company Information Table 57. Charles River Laboratories Business Overview Table 58. Charles River Laboratories Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Charles River Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 60. Charles River Laboratories Recent Development Table 61. WuXi AppTec Company Information Table 62. WuXi AppTec Business Overview Table 63. WuXi AppTec Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. WuXi AppTec Preclinical Pharmacokinetics Services Product Portfolio Table 65. WuXi AppTec Recent Development Table 66. PyschoGenics Company Information Table 67. PyschoGenics Business Overview Table 68. PyschoGenics Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. PyschoGenics Preclinical Pharmacokinetics Services Product Portfolio Table 70. PyschoGenics Recent Development Table 71. Evotec (Cyprotex) Company Information Table 72. Evotec (Cyprotex) Business Overview Table 73. Evotec (Cyprotex) Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Evotec (Cyprotex) Preclinical Pharmacokinetics Services Product Portfolio Table 75. Evotec (Cyprotex) Recent Development Table 76. QPS Company Information Table 77. QPS Business Overview Table 78. QPS Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. QPS Preclinical Pharmacokinetics Services Product Portfolio Table 80. QPS Recent Development Table 81. Aurigene Pharmaceutical Services Company Information Table 82. Aurigene Pharmaceutical Services Business Overview Table 83. Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Product Portfolio Table 85. Aurigene Pharmaceutical Services Recent Development Table 86. Frontage Laboratories Company Information Table 87. Frontage Laboratories Business Overview Table 88. Frontage Laboratories Preclinical Pharmacokinetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Frontage Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 90. Frontage Laboratories Recent Development Table 91. Dalriada Company Information Table 92. Dalriada Business Overview Table 93. Dalriada Preclinical Pharmacokinetics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Dalriada Preclinical Pharmacokinetics Services Product Portfolio Table 95. Dalriada Recent Development Table 96. Sygnature Discovery Company Information Table 97. Sygnature Discovery Business Overview Table 98. Sygnature Discovery Preclinical Pharmacokinetics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Sygnature Discovery Preclinical Pharmacokinetics Services Product Portfolio Table 100. Sygnature Discovery Recent Development Table 101. Admescope Company Information Table 102. Admescope Business Overview Table 103. Admescope Preclinical Pharmacokinetics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Admescope Preclinical Pharmacokinetics Services Product Portfolio Table 105. Admescope Recent Development Table 106. Imavita Company Information Table 107. Imavita Business Overview Table 108. Imavita Preclinical Pharmacokinetics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Imavita Preclinical Pharmacokinetics Services Product Portfolio Table 110. Imavita Recent Development Table 111. IQVIA Laboratories Company Information Table 112. IQVIA Laboratories Business Overview Table 113. IQVIA Laboratories Preclinical Pharmacokinetics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. IQVIA Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 115. IQVIA Laboratories Recent Development Table 116. Pharmaron Company Information Table 117. Pharmaron Business Overview Table 118. Pharmaron Preclinical Pharmacokinetics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Pharmaron Preclinical Pharmacokinetics Services Product Portfolio Table 120. Pharmaron Recent Development Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Preclinical Pharmacokinetics Services Product Image Figure 2. Global Preclinical Pharmacokinetics Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Preclinical Pharmacokinetics Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. LC-MS/MS-Based Preclinical Pharmacokinetics Service Image Figure 8. Immunoassay-Based Preclinical Pharmacokinetics Service Image Figure 9. Others Image Figure 10. Global Preclinical Pharmacokinetics Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Preclinical Pharmacokinetics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Preclinical Pharmacokinetics Services Sales Value Share by Type (2021-2032) Figure 13. Innovative Small Molecule Drugs Image Figure 14. Biopharmaceuticals Image Figure 15. Traditional Chinese Medicine & Natural Products Image Figure 16. Others Image Figure 17. Global Preclinical Pharmacokinetics Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Preclinical Pharmacokinetics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Preclinical Pharmacokinetics Services Sales Value Share by Application (2021-2032) Figure 20. Global Preclinical Pharmacokinetics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Preclinical Pharmacokinetics Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Preclinical Pharmacokinetics Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Preclinical Pharmacokinetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Preclinical Pharmacokinetics Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Preclinical Pharmacokinetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Preclinical Pharmacokinetics Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Preclinical Pharmacokinetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Preclinical Pharmacokinetics Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Preclinical Pharmacokinetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Preclinical Pharmacokinetics Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Preclinical Pharmacokinetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • LC-MS/MS-Based Preclinical Pharmacokinetics Service
  • Immunoassay-Based Preclinical Pharmacokinetics Service
  • Others
Applications
  • Innovative Small Molecule Drugs
  • Biopharmaceuticals
  • Traditional Chinese Medicine & Natural Products
  • Others
Companies covered
  • Porsolt
  • Altasciences
  • Biocytogen
  • Charles River Laboratories
  • WuXi AppTec
  • PyschoGenics
  • Evotec (Cyprotex)
  • QPS
  • Aurigene Pharmaceutical Services
  • Frontage Laboratories
  • Dalriada
  • Sygnature Discovery
  • Admescope
  • Imavita
  • IQVIA Laboratories
  • Pharmaron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Preclinical Pharmacokinetics Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Preclinical Pharmacokinetics Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Preclinical Pharmacokinetics Services Market Dynamics
  1. 2.1 Preclinical Pharmacokinetics Services Industry Trends
  2. 2.2 Preclinical Pharmacokinetics Services Industry Drivers
  3. 2.3 Preclinical Pharmacokinetics Services Industry Opportunities and Challenges
  4. 2.4 Preclinical Pharmacokinetics Services Industry Restraints
3 Preclinical Pharmacokinetics Services Market by Company
  1. 3.1 Global Preclinical Pharmacokinetics Services Company Revenue Ranking in 2025
  2. 3.2 Global Preclinical Pharmacokinetics Services Revenue by Company (2021-2026)
  3. 3.3 Global Preclinical Pharmacokinetics Services Company Ranking (2024-2026)
  4. 3.4 Global Preclinical Pharmacokinetics Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Preclinical Pharmacokinetics Services Company Product Type and Application
  6. 3.6 Global Preclinical Pharmacokinetics Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Preclinical Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Preclinical Pharmacokinetics Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Preclinical Pharmacokinetics Services Market by Type
  1. 4.1 Preclinical Pharmacokinetics Services Type Introduction
  2. 4.1.1 LC-MS/MS-Based Preclinical Pharmacokinetics Service
  3. 4.1.2 Immunoassay-Based Preclinical Pharmacokinetics Service
  4. 4.1.3 Others
  5. 4.2 Global Preclinical Pharmacokinetics Services Sales Value by Type
  6. 4.2.1 Global Preclinical Pharmacokinetics Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Preclinical Pharmacokinetics Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Preclinical Pharmacokinetics Services Sales Value Share by Type (2021-2032)
5 Preclinical Pharmacokinetics Services Market by Application
  1. 5.1 Preclinical Pharmacokinetics Services Application Introduction
  2. 5.1.1 Innovative Small Molecule Drugs
  3. 5.1.2 Biopharmaceuticals
  4. 5.1.3 Traditional Chinese Medicine & Natural Products
  5. 5.1.4 Others
  6. 5.2 Global Preclinical Pharmacokinetics Services Sales Value by Application
  7. 5.2.1 Global Preclinical Pharmacokinetics Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Preclinical Pharmacokinetics Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Preclinical Pharmacokinetics Services Sales Value Share by Application (2021-2032)
6 Preclinical Pharmacokinetics Services Regional Value Analysis
  1. 6.1 Global Preclinical Pharmacokinetics Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Preclinical Pharmacokinetics Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Preclinical Pharmacokinetics Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Preclinical Pharmacokinetics Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Preclinical Pharmacokinetics Services Sales Value (2021-2032)
  7. 6.3.2 North America Preclinical Pharmacokinetics Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Preclinical Pharmacokinetics Services Sales Value (2021-2032)
  10. 6.4.2 Europe Preclinical Pharmacokinetics Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Preclinical Pharmacokinetics Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Preclinical Pharmacokinetics Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Preclinical Pharmacokinetics Services Sales Value (2021-2032)
  16. 6.6.2 South America Preclinical Pharmacokinetics Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Preclinical Pharmacokinetics Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Preclinical Pharmacokinetics Services Sales Value Share by Country, 2025 VS 2032
7 Preclinical Pharmacokinetics Services Country-level Value Analysis
  1. 7.1 Global Preclinical Pharmacokinetics Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Preclinical Pharmacokinetics Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Preclinical Pharmacokinetics Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Preclinical Pharmacokinetics Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Preclinical Pharmacokinetics Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Preclinical Pharmacokinetics Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Preclinical Pharmacokinetics Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Porsolt
  2. 8.1.1 Porsolt Company Information
  3. 8.1.2 Porsolt Business Overview
  4. 8.1.3 Porsolt Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Porsolt Preclinical Pharmacokinetics Services Product Portfolio
  6. 8.1.5 Porsolt Recent Developments
  7. 8.2 Altasciences
  8. 8.2.1 Altasciences Company Information
  9. 8.2.2 Altasciences Business Overview
  10. 8.2.3 Altasciences Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Altasciences Preclinical Pharmacokinetics Services Product Portfolio
  12. 8.2.5 Altasciences Recent Developments
  13. 8.3 Biocytogen
  14. 8.3.1 Biocytogen Company Information
  15. 8.3.2 Biocytogen Business Overview
  16. 8.3.3 Biocytogen Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biocytogen Preclinical Pharmacokinetics Services Product Portfolio
  18. 8.3.5 Biocytogen Recent Developments
  19. 8.4 Charles River Laboratories
  20. 8.4.1 Charles River Laboratories Company Information
  21. 8.4.2 Charles River Laboratories Business Overview
  22. 8.4.3 Charles River Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  24. 8.4.5 Charles River Laboratories Recent Developments
  25. 8.5 WuXi AppTec
  26. 8.5.1 WuXi AppTec Company Information
  27. 8.5.2 WuXi AppTec Business Overview
  28. 8.5.3 WuXi AppTec Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi AppTec Preclinical Pharmacokinetics Services Product Portfolio
  30. 8.5.5 WuXi AppTec Recent Developments
  31. 8.6 PyschoGenics
  32. 8.6.1 PyschoGenics Company Information
  33. 8.6.2 PyschoGenics Business Overview
  34. 8.6.3 PyschoGenics Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PyschoGenics Preclinical Pharmacokinetics Services Product Portfolio
  36. 8.6.5 PyschoGenics Recent Developments
  37. 8.7 Evotec (Cyprotex)
  38. 8.7.1 Evotec (Cyprotex) Company Information
  39. 8.7.2 Evotec (Cyprotex) Business Overview
  40. 8.7.3 Evotec (Cyprotex) Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Evotec (Cyprotex) Preclinical Pharmacokinetics Services Product Portfolio
  42. 8.7.5 Evotec (Cyprotex) Recent Developments
  43. 8.8 QPS
  44. 8.8.1 QPS Company Information
  45. 8.8.2 QPS Business Overview
  46. 8.8.3 QPS Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 QPS Preclinical Pharmacokinetics Services Product Portfolio
  48. 8.8.5 QPS Recent Developments
  49. 8.9 Aurigene Pharmaceutical Services
  50. 8.9.1 Aurigene Pharmaceutical Services Company Information
  51. 8.9.2 Aurigene Pharmaceutical Services Business Overview
  52. 8.9.3 Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Product Portfolio
  54. 8.9.5 Aurigene Pharmaceutical Services Recent Developments
  55. 8.10 Frontage Laboratories
  56. 8.10.1 Frontage Laboratories Company Information
  57. 8.10.2 Frontage Laboratories Business Overview
  58. 8.10.3 Frontage Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Frontage Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  60. 8.10.5 Frontage Laboratories Recent Developments
  61. 8.11 Dalriada
  62. 8.11.1 Dalriada Company Information
  63. 8.11.2 Dalriada Business Overview
  64. 8.11.3 Dalriada Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dalriada Preclinical Pharmacokinetics Services Product Portfolio
  66. 8.11.5 Dalriada Recent Developments
  67. 8.12 Sygnature Discovery
  68. 8.12.1 Sygnature Discovery Company Information
  69. 8.12.2 Sygnature Discovery Business Overview
  70. 8.12.3 Sygnature Discovery Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sygnature Discovery Preclinical Pharmacokinetics Services Product Portfolio
  72. 8.12.5 Sygnature Discovery Recent Developments
  73. 8.13 Admescope
  74. 8.13.1 Admescope Company Information
  75. 8.13.2 Admescope Business Overview
  76. 8.13.3 Admescope Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Admescope Preclinical Pharmacokinetics Services Product Portfolio
  78. 8.13.5 Admescope Recent Developments
  79. 8.14 Imavita
  80. 8.14.1 Imavita Company Information
  81. 8.14.2 Imavita Business Overview
  82. 8.14.3 Imavita Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Imavita Preclinical Pharmacokinetics Services Product Portfolio
  84. 8.14.5 Imavita Recent Developments
  85. 8.15 IQVIA Laboratories
  86. 8.15.1 IQVIA Laboratories Company Information
  87. 8.15.2 IQVIA Laboratories Business Overview
  88. 8.15.3 IQVIA Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 IQVIA Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  90. 8.15.5 IQVIA Laboratories Recent Developments
  91. 8.16 Pharmaron
  92. 8.16.1 Pharmaron Company Information
  93. 8.16.2 Pharmaron Business Overview
  94. 8.16.3 Pharmaron Preclinical Pharmacokinetics Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Pharmaron Preclinical Pharmacokinetics Services Product Portfolio
  96. 8.16.5 Pharmaron Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst